Natco Pharma gets EIR from USFDA for Telangana facility

By Economic Times – Natco Pharma gets EIR from USFDA for Telangana facility The United States Food and Drug Administration (USFDA) had conducted pre-approval inspection at the company’s drug formulations facility in Kothur village during the period from March 2 to 6, 2020, Natco Pharma said in a filing to the BSE. PTI|Last Updated: Apr 25, 2020, 01.49 PM ISTAgencies Natco Pharma (File Photo)New Delhi: Drug firm Natco Pharma on Saturday said it has received establishment inspection report (EIR) from the US health regulator for its Kothur facility in Telangana.
The United States Food and Drug Administration (USFDA) had conducted pre-approval inspection at the company’s drug formulations facility in Kothur village during the period from March 2 to 6, 2020, Natco Pharma said in a filing to the BSE.
The EIR signifies successful closure of inspection by the regulator, it added.
Also Read212 virus containment clusters marked in TelanganaProvide shelter, food to migrants: Telangana govtStudents from Telangana, Andhra Pradesh stranded in ItalyCOVID-19: Central teams rushed to visit Gujarat, Tamil Nadu, TelanganaCommentsAdd Your CommentsCommenting feature is disabled in your country/region.
For more details, please visit https://ift.tt/2S7rSEb
The post Natco Pharma gets EIR from USFDA for Telangana facility appeared first on Stay in Gurgaon.
Comments
Post a Comment